Novozymes reported 10.86B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Arq USD 167.81M 151K Mar/2026
Avient USD 2.41B 31.6M Mar/2026
Chemours USD 215M 35M Mar/2026
Coronado Global Resources USD 649.75M 252M Dec/2025
Corteva USD 24.36B 218M Mar/2026
Metallus USD 683M 3M Mar/2026
Newmont Corporation USD 33.41B 1.12B Sep/2025
Novozymes 10.86B 111.1M Dec/2025
SSR Mining USD 4.43B 920.99M Mar/2026